Bortezomib-based combination regimens in myeloma: More is not necessarily better

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Bortezomib-based combination regimens in myeloma: More is not necessarily better'. Together they form a unique fingerprint.